Fluor Reports Q1 Profit & Positive Cash Flow Driven by NuScale Divestiture, Initiates Substantial Share Buyback

summarizeSummary

Fluor reported a return to profitability and positive operating cash flow in Q1 2026, fueled by $1.35 billion from NuScale share sales and a $124 million gain from the CFHI divestiture, while also initiating a significant share repurchase program.

check_boxKey Events

• Return to Profitability and Positive Operating Cash Flow

  Net earnings attributable to Fluor swung to a profit of $160 million in Q1 2026 from a loss of $241 million in Q1 2025. Operating cash flow significantly improved to $110 million from a negative $286 million in the prior year period.

• Completed NuScale Divestiture and CFHI Sale

  The company completed the sale of 71 million NuScale shares in February 2026 for $1.35 billion and the final 40 million shares in April 2026 for $473 million, bringing total proceeds from NuScale sales since September 2025 to $2.43 billion. Additionally, Fluor sold its ownership in CFHI for $124 million, recognizing a gain.

• Significant Share Repurchase Program Underway

  Fluor repurchased 11 million shares for $516 million in Q1 2026. The board authorized a 30 million share expansion in February 2026, targeting approximately $1.4 billion in repurchases for the year, with over 28 million shares remaining under authorization.

• Revenue Decline and Decreased New Awards

  Revenue decreased 8% to $3.66 billion in Q1 2026 from $3.98 billion in Q1 2025. New awards also saw a significant decline to $2.69 billion from $5.81 billion in the prior year, though total backlog remained stable at $25.73 billion.

auto_awesomeAnalysis

Fluor's Q1 2026 results show a significant turnaround in profitability and cash flow, primarily driven by the successful divestiture of its NuScale investment and the sale of CFHI. The company generated substantial cash proceeds, which it is actively deploying through a large share repurchase program. While revenue declined and new awards decreased, and legal challenges persist, the strategic capital allocation and improved liquidity are strong positive signals for the company's financial health and commitment to shareholder returns. Investors should monitor the execution of the buyback program and the resolution of ongoing legal matters.